On May 22, 2025, Tianjin Proliotics Biotechnology Co., Ltd. reported good news: Mr. Zhang Minghuang, the chairman, was invited to join the "American Society of Anti Aging Medicine" and officially became a member.

he American Academy of Anti Aging Medicine (A4M) was founded in 1992 by Dr. ROBERT GOLDMAN and Dr. RONALD KLATZ. It is a non-profit organization dedicated to anti-aging medical research.

The society aims to redefine the forward-looking mission of modern medicine, committed to researching and promoting advanced detection, prevention, and treatment of age-related diseases, promoting methods to delay and optimize the human aging process. It also focuses on training doctors, scientists, health practitioners, and the public on anti-aging issues and certifying medical staff. It has created a new systematic discipline that integrates detection, proactive prevention, health care, and personalized treatment, namely the discipline of anti-aging medicine.
Nowadays, A4M has developed into the world's most extensive and influential anti-aging medical organization, and the only one with a training, certification, and examination system. It includes over 120 countries and regions worldwide, with 50000 doctors, scientists, and industry experts.
Mr. Zhang Minghuang has been deeply involved in the field of aging and the prevention and treatment of related diseases caused by aging for many years, possessing rich professional knowledge and strong scientific foundation. Tianjin Prolide Biotechnology Co., Ltd., under its name, is also a high-tech enterprise dedicated to basic research and exploration in the fields of "cell regeneration" and "immune regulation", and engaged in the research and development, production, and sales of anti-aging products related to them. It has won honors such as "High tech Enterprise" and "China Famous Brand", and has become a model enterprise in the big health industry.
Mr. Zhang Minghuang's special invitation to join not only injects fresh blood and strong strength into the society, but also undoubtedly marks another important milestone for the company, which has had an extremely positive and profound impact on the steady progress of "Prolipropeptide".